Vistagen Therapeutics Inc
(VTGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Operating Expenses | 4,078 | 2,868 | 4,994 | 2,261 | 2,548 |
| Operating Income | -4,078 | -2,868 | -4,994 | -2,261 | -2,548 |
| Interest Expense | 1 | 2 | 3 | 2 | 1 |
| Other Income | 0 | -135 | 0 | 0 | 0 |
| Pre-tax Income | -4,079 | -3,005 | -4,997 | -2,263 | -2,549 |
| Income Tax | 5 | N/A | N/A | -2 | N/A |
| Net Income Continuous | -4,084 | -3,005 | -4,997 | -2,261 | -2,549 |
| Net Income | $-4,079 | $-3,005 | $-4,997 | $-2,265 | $-2,549 |
| EPS Basic Total Ops | -1.80 | -7.51 | -15.92 | -8.41 | -8.11 |
| EPS Basic Continuous Ops | -1.84 | -6.49 | -15.17 | -7.51 | -8.27 |
| EPS Diluted Total Ops | -1.80 | -7.51 | -15.92 | -8.41 | -8.11 |
| EPS Diluted Continuous Ops | -1.84 | -6.49 | -15.17 | -7.51 | -8.27 |
| EBITDA(a) | $-4,062 | $-2,849 | $-5,034 | $-2,174 | $-2,467 |